Novartis Ag (NVSEF) Net Income Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Net Income Growth (5y) (2014 - 2025) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Novartis Ag	-	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2025	17.10%
Dec 31, 2024	8,120.97%
Jun 30, 2024	-1.11%
Dec 31, 2023	14.87%
Jun 30, 2023	2.83%
Dec 31, 2022	-39.50%
Jun 30, 2022	0.63%
Mar 31, 2022	-3.67%
Dec 31, 2021	22.52%
Sep 30, 2021	-1.46%
Jun 30, 2021	19.48%
Mar 31, 2021	-47.35%
Dec 31, 2020	385.03%
Jun 30, 2020	18,602.14%
Mar 31, 2020	3,273.52%
Dec 31, 2019	14.89%
Sep 30, 2019	-3,094.38%
Jun 30, 2019	14,987.69%
Mar 31, 2019	-1,044.65%
Dec 31, 2018	-1,333.18%